Innovacell
↗Tokyo, Japan
Innovacell is a clinical-stage biotechnology company focused on the development and commercialization of autologous cell therapies for the treatment of fecal and urinary incontinence. The company's proprietary technology involves extracting a patient's own skeletal muscle cells, expanding them in a specialized manufacturing facility, and re-injecting them into the weakened sphincter muscle to promote tissue regeneration and restore function.
Originally founded in 2000 as a spin-off from the Medical University of Innsbruck in Austria, the company restructured in 2021 to establish its global headquarters in Tokyo, Japan. This strategic move was designed to leverage Japan's favorable regulatory environment for regenerative medicine. Innovacell successfully listed on the Tokyo Stock Exchange Growth Market in February 2026, marking a significant milestone in its path toward global commercialization of its lead therapies.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Regenerative Medicine / Cell Therapy
SIZE & FINANCIALS
Employees:1-50
Revenue:$0M-$10M
Founded:2000
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:$120M
Investors:M&G Investments, Alfresa Holdings, SBI Investment, Rheos Capital Works, Happiness Capital, Alpine Equity, European Investment Bank
STOCK
Exchange:TSE
Ticker:504A
Market Cap:$91M
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3
Modalities:Cell therapy, Autologous skeletal myoblasts
Active Trials:2
Trial Phases:Phase 1: 1 | Phase 2: 1 | Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Innovacell GmbH (Austria)
Key Partnerships:Alfresa Corporation (Distribution and logistics in Japan), Nomura Securities (Lead IPO underwriter)
COMPETITION
Position:Emerging
Competitors:Axonics, Coloplast, Cook Myosite, MUVON Therapeutics, Orgenesis
LEADERSHIP
Key Executives:
Colin Lee Novick - Co-CEO
Jason David Sieger - Co-CEO
Dr. Rainer Marksteiner - Founder & Director
Scientific Founders:Dr. Rainer Marksteiner
Board Members:Dr. Harald Pöttinger (Chairman), Colin Lee Novick, Jason David Sieger
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Innovacell. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.